Overview

Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

Status:
Completed
Trial end date:
2016-08-25
Target enrollment:
Participant gender:
Summary
A Phase 1, Single-center, Open-label, Pharmacokinetic, Safety and Tolerability Study of SB204 in Adolescents with Moderate to Severe Acne Vulgaris
Phase:
Phase 1
Details
Lead Sponsor:
Novan, Inc.
Collaborator:
WCCT Global